- Open
- 236.60
- High
- 238.40
- Low
- 235.00
- Close
- 235.80
- Change
- +0.00 (0.00%)
- Volume
- 6,319,300
| 20 Oct 2026 | 11:00:00 | Holding(s) in Company |
| 14 Oct 2026 | 11:00:00 | Director/PDMR Shareholding |
| 12 Oct 2026 | 11:00:00 | Transaction in Own Shares |
| 5 Oct 2026 | 11:00:00 | Transaction in Own Shares |
| 10 Mar 2026 | Convatec Group Plc 2025 Annual Report | |
| 10 Mar 2026 | Annual Report and Accounts for the year ending 31 December 2025 | |
| 11 Mar 2025 | Convatec Group Plc 2024 Annual Report and Accounts |
Convatec Group plc develops and manufactures medical products and technologies focused on chronic care. Its primary business segments include Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, providing solutions for managing wounds, stomas, urinary issues, and infusion therapies. The company serves healthcare professionals and patients globally, with significant operations in North America and Europe, and generates over 90% of its revenue from recurring consumable products.
| 20 Oct 2026 | 11:00:00 | Holding(s) in Company |
| 14 Oct 2026 | 11:00:00 | Director/PDMR Shareholding |
| 12 Oct 2026 | 11:00:00 | Transaction in Own Shares |
| 5 Oct 2026 | 11:00:00 | Transaction in Own Shares |
| 10 Mar 2026 | Convatec Group Plc 2025 Annual Report | |
| 10 Mar 2026 | Annual Report and Accounts for the year ending 31 December 2025 | |
| 11 Mar 2025 | Convatec Group Plc 2024 Annual Report and Accounts |
Convatec Group plc develops and manufactures medical products and technologies focused on chronic care. Its primary business segments include Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, providing solutions for managing wounds, stomas, urinary issues, and infusion therapies. The company serves healthcare professionals and patients globally, with significant operations in North America and Europe, and generates over 90% of its revenue from recurring consumable products.
| 2 Oct 2026 |
| 11:00:00 |
| Holding(s) in Company |
| 29 Sept 2026 |
| FTSE 100 movers: Energy shares dip; miners rally as copper prices rise |
| 29 Sept 2026 | FTSE 100: oil shares fall as pharma provides support |
| 27 Aug 2026 | Convatec appoints Jens Viebke as Non-Executive Director |
| 4 Aug 2026 | FTSE 100 Live: Miners offset HSBC slide, while Palantir and Caterpillar surge |
| 4 Aug 2026 | FTSE 100 Live: Mining surge offsets BP slide, while HSBC buyback 'too small' |
| 31 Jul 2026 | Week Ahead: BP, HSBC, L&G, Glencore, Diageo, Persimmon |
| 2 Oct 2026 |
| 11:00:00 |
| Holding(s) in Company |
| 29 Sept 2026 |
| FTSE 100 movers: Energy shares dip; miners rally as copper prices rise |
| 29 Sept 2026 | FTSE 100: oil shares fall as pharma provides support |
| 27 Aug 2026 | Convatec appoints Jens Viebke as Non-Executive Director |
| 4 Aug 2026 | FTSE 100 Live: Miners offset HSBC slide, while Palantir and Caterpillar surge |
| 4 Aug 2026 | FTSE 100 Live: Mining surge offsets BP slide, while HSBC buyback 'too small' |
| 31 Jul 2026 | Week Ahead: BP, HSBC, L&G, Glencore, Diageo, Persimmon |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £9.10bn | -0.2% | |
CTECConvatec Group plc | £4.51bn | -0.0% |
| £3.42bn | -0.1% | |
| £624m | +0.3% | |
| £283m | -0.0% | |
| £66m | -0.3% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £9.10bn | -0.2% | |
CTECConvatec Group plc | £4.51bn | -0.0% |
| £3.42bn | -0.1% | |
| £624m | +0.3% | |
| £283m | -0.0% | |
| £66m | -0.3% |